A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Advanced Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Contact: Study coordinator (Qin Li, Doctor) · qinli128003@163.com · 13701288153
Fujian Cancer Hospital, Fuzhou, Fujian, China
Contact: Study coordinator (Yang Sun, Doctor) · doctorsunyang@sina.com · 15959028989
Meizhou People's Hospital (Meizhou Academy of Medical Sciences), Meizhou, Guangdong, China
Contact: Study coordinator (Yibiao Chen, Bachelor) · cybhtyy812@163.com · 13751962821
Shanghai Tenth People's Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Xiaojun Chen, Doctor) · cxjlhjj@163.com · 13601680784
Sichuan Cancer Hospital, Chengdu, Sichuan, China
Contact: Study coordinator (Guonan Zhang, Doctor) · zhanggn@hotmail.com · 13881866599

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Cancer · Tumor, Solid · Malignant Neoplasm

Abroad (travel likely)RecruitingPHASE1, PHASE2

Austin, United States · Irving, United States

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

Sleep · Fatigue · Anxiety

Abroad (travel likely)RecruitingPHASE2, PHASE3

Houston, United States